Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Biochemical Assay for PERK from US Patent US11912668: "GCN2 and perk kinase inhibitors and methods of use thereof"
Assay data:159 Active, 130 Activity ≤ 1 µM, 159 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
Inhibition of PERK (unknown origin)
Assay data:6 Active, 6 Activity ≤ 1 µM, 6 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Biochemical Assay for PERK from US Patent US20230382915: "GCN2 AND PERK KINASE INHIBITORS AND METHODS OF USE THEREOF"
Assay data:30 Active, 29 Activity ≤ 1 µM, 30 Tested
PERK enzyme assays from US Patent US11491158: "N-(substituted-phenyl)-sulfonamide derivatives as kinase inhibitors"
Assay data:57 Active, 66 Activity ≤ 1 µM, 66 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Inhibition of PERK (unknown origin) assessed as fold change
Assay data:1 Tested
SummaryPubMed CitationRelated BioAssays by Target
PEK(h) Kinase panel
SummaryRelated BioAssays by Target
Inhibition of human His-tagged PERK by TR-FRET assay
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Inhibition of human recombinant PEK assessed as reduction in substrate phosphorylation at 50 to 500 nM using ATP and Ulight-CKKSRGDYMTMQIG (IRS-1) incubated for 60 min by LANCE detection method
Quantification of the Phosphorylated Product Formed from the Kinase Reaction in Presence of ATP from US Patent US10918642: "N-(substituted-phenyl)-sulfonamide derivatives as kinase inhibitors"
Assay data:3 Active, 6 Activity ≤ 1 µM, 6 Tested
ADP-Glo Kinase Assay from US Patent US10918642: "N-(substituted-phenyl)-sulfonamide derivatives as kinase inhibitors"
Assay data:56 Active, 62 Activity ≤ 1 µM, 62 Tested
MPS1/PERK Biochemical Assay from US Patent US9333205: "Isoxazolo-quinazolines as modulators of protein kinase activity"
Assay data:3 Active, 3 Activity ≤ 1 µM, 3 Tested
pERK AlphaScreen Protocol from US Patent US10280171: "Heterocyclic inhibitors of PTPN11"
Assay data:85 Active, 68 Activity ≤ 1 µM, 86 Tested
Alpha Elisa Assay from US Patent US9695165: "Inhibitors of the fibroblast growth factor receptor"
Assay data:26 Active, 26 Activity ≤ 1 µM, 26 Tested
PERK [PEK(EIK3CGQ1)] Takeda global kinase panel
Assay data:1 Activity ≤ 1 µM, 1 Tested
SummaryCompounds, activity ≤ 1 µMRelated BioAssays by Target
PEK(h) Eurofins kinase panel
EIF2AK3 ProQinase selectivity panel
PEK(h) Eurofins Kinase panel
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on